NVO20260807C45
NVO Aug 7 2026 45.00 Call (NVO260807C00045000)
option OPRA

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.